Case Note & Summary
The case involved a public interest litigation filed by an advocate seeking directions from the Supreme Court to ban the import, manufacture, sale, and distribution of drugs that have been banned in Western countries or recommended for banning by the Drugs Consultative Committee under the Drugs and Cosmetics Act, 1940. The petitioner sought the cancellation of licenses for such drugs and the establishment of a high-powered authority to assess the hazards posed by these drugs and suggest remedial measures. The Supreme Court emphasized the duty of statutory bodies to respond to its notices, highlighting the importance of their participation in public interest matters. The Court recognized the complexity and technical nature of drug regulation, asserting that such matters are not appropriate for judicial determination and should be left to the Union Government. The Court underscored the State's obligation to ensure public health and the availability of safe drugs, calling for a strengthened regulatory framework to eliminate harmful drugs from the market. The Court also noted the need for a central enforcement mechanism and encouraged the government to develop a comprehensive drug policy. Ultimately, the Court directed the Ministry of Health to deposit a sum of Rs.5000 in the Court for the petitioner as reimbursement for expenses incurred in bringing the matter before the Court.
Headnote
A) Constitutional Law - Public Interest Litigation - Duty of Statutory Bodies - Article 144 of the Constitution of India, 1950 - Statutory bodies are required to respond to the Supreme Court's notices and participate in proceedings, as they are not ordinary litigants. The Court emphasized the importance of their involvement in matters of public interest, particularly concerning health and safety (Paras 475G-H; 476A-B). B) Health Law - Judicial Review of Drug Policy - Article 47 of the Constitution of India, 1950 - The Court held that the complexity and technical nature of drug regulation matters are not suitable for judicial determination, and such policy decisions are primarily the responsibility of the Union Government (Paras 476H; 477A). C) Health Care - Regulation of Drugs - Article 47 of the Constitution of India, 1950 - The State has a primary duty to improve public health and ensure the availability of safe and effective drugs. The Court noted the need for a robust regulatory framework to eliminate harmful drugs from the market (Paras 479G-H; 480A-B).
Issue of Consideration
Whether the Supreme Court could interfere with government drug policy and the obligations under Article 47 of the Constitution.
Final Decision
The Supreme Court directed the Ministry of Health to deposit Rs.5000 in the Court for the petitioner and emphasized the need for a robust regulatory framework for drug safety and public health. The Court held that the matter was not suitable for judicial determination and should be addressed by the Union Government.
Law Points
- Public Interest Litigation
- Article 144
- Drugs and Cosmetics Act
- 1940
- Article 47
- Health Care
- Judicial Review
- Statutory Obligations
